Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Sinclair

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Headache|May 9, 2014
Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registrySara A Ephross, Susan M Sinclair
Journal of Blood Medicine|October 8, 2025
Safety of Recombinant von Willebrand Factor in the Treatment of von Willebrand Disease: Real-World Data from an EU Post-Authorization Safety StudySusan M Sinclair, Yi Ba, Kayode Badejo
Rheumatology and Therapy|July 30, 2020
An Innovative Online Qualitative Study to Explore the Symptom Experience of Patients with Primary Sjögren's SyndromeKerry Gairy, Keith Ruark, Susan M Sinclair, et al.
Journal of Midwifery & Women'S Health|January 16, 2016
Medication Safety During Pregnancy: Improving Evidence-Based PracticeSusan M Sinclair, Richard K Miller, Christina Chambers, et al.
Birth Defects Research|October 28, 2022
Final results from the ribavirin pregnancy registry, 2004-2020Susan M Sinclair, Judith K Jones, Richard K Miller, et al.
Drug Safety|July 10, 2017
The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of EnrollmentSusan M Sinclair, Judith K Jones, Richard K Miller, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Headache|May 9, 2014
Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registrySara A Ephross, Susan M Sinclair
Journal of Blood Medicine|October 8, 2025
Safety of Recombinant von Willebrand Factor in the Treatment of von Willebrand Disease: Real-World Data from an EU Post-Authorization Safety StudySusan M Sinclair, Yi Ba, Kayode Badejo
Rheumatology and Therapy|July 30, 2020
An Innovative Online Qualitative Study to Explore the Symptom Experience of Patients with Primary Sjögren's SyndromeKerry Gairy, Keith Ruark, Susan M Sinclair, et al.
Journal of Midwifery & Women'S Health|January 16, 2016
Medication Safety During Pregnancy: Improving Evidence-Based PracticeSusan M Sinclair, Richard K Miller, Christina Chambers, et al.
Birth Defects Research|October 28, 2022
Final results from the ribavirin pregnancy registry, 2004-2020Susan M Sinclair, Judith K Jones, Richard K Miller, et al.
Drug Safety|July 10, 2017
The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of EnrollmentSusan M Sinclair, Judith K Jones, Richard K Miller, et al.
Pageof 1